150 related articles for article (PubMed ID: 2024957)
1. Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.
Derouin F; Piketty C; Chastang C; Chau F; Rouveix B; Pocidalo JJ
Antimicrob Agents Chemother; 1991 Feb; 35(2):252-5. PubMed ID: 2024957
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
4. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
Chang HR; Arsenijevic D; Comte R; Polak A; Then RL; Pechère JC
Antimicrob Agents Chemother; 1994 Aug; 38(8):1803-7. PubMed ID: 7986011
[TBL] [Abstract][Full Text] [Related]
5. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
Romand S; Della Bruna C; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice.
Piketty C; Derouin F; Rouveix B; Pocidalo JJ
Antimicrob Agents Chemother; 1990 Aug; 34(8):1467-72. PubMed ID: 2221854
[TBL] [Abstract][Full Text] [Related]
8. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
[TBL] [Abstract][Full Text] [Related]
9. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
11. Activity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondii.
Khan AA; Slifer TR; Araujo FG; Remington JS
Antimicrob Agents Chemother; 2001 Jan; 45(1):48-51. PubMed ID: 11120943
[TBL] [Abstract][Full Text] [Related]
12. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.
Abugri DA; Witola WH; Russell AE; Troy RM
Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Alder J; Hutch T; Meulbroek JA; Clement JC
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
[TBL] [Abstract][Full Text] [Related]
15. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
[TBL] [Abstract][Full Text] [Related]
16. Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice.
BEVERLEY JK; FRY BA
Br J Pharmacol Chemother; 1957 Jun; 12(2):189-93. PubMed ID: 13446372
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
[TBL] [Abstract][Full Text] [Related]
18. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
Mehlhorn H; Dankert W; Hartman PG; Then RL
Parasitol Res; 1995; 81(4):296-301. PubMed ID: 7624286
[TBL] [Abstract][Full Text] [Related]
19. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
Mahmoud MS
J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
[TBL] [Abstract][Full Text] [Related]
20. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
